Publicaciones en colaboración con investigadoras/es de Queen's University Belfast (20)

2023

  1. Erratum: Nanodiamonds Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases (ACS Appl. Mater. Interfaces (2022) 14:11 (13665−13677) DOI: 10.1021/acsami.2c02182)

    ACS Applied Materials and Interfaces

  2. Long-term biophysical stability of nanodiamonds combined with lipid nanocarriers for non-viral gene delivery to the retina

    International Journal of Pharmaceutics, Vol. 639

2022

  1. Nanodiamond Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases

    ACS Applied Materials and Interfaces, Vol. 14, Núm. 11, pp. 13665-13677

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2010

  1. High affinity binding of hydrophobic and autoantigenic regions of proinsulin to the 70 kDa chaperone DnaK

    BMC Biochemistry, Vol. 11, Núm. 1

  2. Inhibition of secretion of interleukin (IL)-12/IL-23 family cytokines by 4-trifluoromethyl-celecoxib is coupled to degradation via the endoplasmic reticulum stress protein HERP

    Journal of Biological Chemistry, Vol. 285, Núm. 10, pp. 6960-6969

2009

  1. IL7RA polymorphisms and chronic inflammatory arthropathies

    Tissue Antigens

2006

  1. Celecoxib inhibits interleukin-12 αβ and β2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum

    Molecular Pharmacology, Vol. 69, Núm. 5, pp. 1579-1587

  2. Multi-chaperone complexes regulate the folding of interferon-γ in the endoplasmic reticulum

    Cytokine, Vol. 33, Núm. 5, pp. 264-273

2005

  1. IFNG polymorphisms are associated with gender differences in susceptibiligy to multiple sclerosis

    Genes and Immunity, Vol. 6, Núm. 2, pp. 153-161

  2. Polymorphisms in the interleukin-4 and IL-4 receptor genes and multiple sclerosis: A study in Spanish-Basque, Northern Irish and Belgian populations

    International Journal of Immunogenetics, Vol. 32, Núm. 6, pp. 383-388

  3. The CTLA4 +49 A/G*G-CT60*G haplotype is associated with susceptibility to multiple sclerosis in Flanders

    Journal of Neuroimmunology, Vol. 164, Núm. 1-2, pp. 148-153

  4. The metallopeptide antibiotic bacitracin inhibits interleukin-12 αβ and β2 secretion

    Journal of Pharmacy and Pharmacology, Vol. 57, Núm. 2, pp. 213-218

2004

  1. Cross-linking approach to affinity capture of protein complexes from chaotrope-solubilized cell lysates

    Analytical Biochemistry, Vol. 324, Núm. 1, pp. 137-142

  2. Inhibiting cytokines of the interleukin-12 family: Recent advances and novel challenges

    Journal of Pharmacy and Pharmacology, Vol. 56, Núm. 2, pp. 145-160

2003

  1. Polymorphisms in the Interferon-γ/Interleukin-26 Gene Region Contribute to Sex Bias in Susceptibility to Rheumatoid Arthritis

    Arthritis and Rheumatism, Vol. 48, Núm. 10, pp. 2773-2778

2002

  1. Interleukin-12 p40 polymorphism and susceptibility to multiple sclerosis [2]

    Annals of Neurology

  2. The conserved helix C region in the superfamily of interferon-γ/interleukin-10-related cytokines corresponds to a high-affinity binding site for the HSP70 chaperone DnaK

    Journal of Biological Chemistry, Vol. 277, Núm. 28, pp. 25668-25676

2000

  1. Protein disulfide isomerase-mediated cell-free assembly of recombinant interleukin-12 p40 homodimers

    European Journal of Biochemistry, Vol. 267, Núm. 22, pp. 6679-6683